{"id":"NCT00418262","sponsor":"University of Oklahoma","briefTitle":"Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD","officialTitle":"An Open-label Study of the Long Term Tolerability and Safety of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal-Alcohol Syndrome or Effects.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-08","primaryCompletion":"2015-04-22","completion":"2015-04-22","firstPosted":"2007-01-04","resultsPosted":"2017-07-02","lastUpdate":"2017-07-02"},"enrollment":27,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Fetal Alcohol Syndrome","Attention Deficit Hyperactivity Disorder (ADHD)"],"interventions":[{"type":"DRUG","name":"Atomoxetine","otherNames":["Brand Name: Strattera, Serial Number: 76306506, ACT"]}],"arms":[{"label":"Atomoxetine HCL (Strattera)","type":"EXPERIMENTAL"}],"summary":"Determine if atomoxetine is safe and well tolerated by children with fetal alcohol syndrome.","primaryOutcome":{"measure":"Pittsburg Side-Effects Scale: Motor Tics","timeFrame":"12 months or study duration","effectByArm":[{"arm":"Atomoxetine HCL (Strattera)","deltaMin":0.15,"sd":0.54}],"pValues":[{"comp":"OG000","p":null},{"comp":"OG000","p":null}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":26},"commonTop":["Cough","Vomiting","Headache","Stomachache","Sleepy or Sleep Trouble"]}}